Novavax (NVAX) Share-based Compensation (2010 - 2026)
Novavax's Share-based Compensation was $8.09 million in Q2 2026, down 12.2% from $9.21 million a year earlier but up 4.7% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Share-based Compensation (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Novavax's Share-based Compensation was $32.33 million through Jun 30, 2026, down 23.0% year-over-year; for FY2025, it was $36.02 million, down 25.2% from FY2024.
- Share-based Compensation has now declined for four consecutive years, with a five-year compound annual growth rate of -22.4% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $48.15 million in FY2024 (-43.6%), $85.36 million in FY2023 (-34.5%), $130.3 million in FY2022 (-29.0%) and $183.63 million in FY2021 (+43.4%).
- Quarterly Share-based Compensation has moved between $7.72 million (Q1 2026) and $45.27 million (Q3 2021) over five years.
- Compared with a year earlier, Share-based Compensation has declined for 20 straight quarters, with an average decline of 26.3% over the last eight quarters.
- Across the past five years, year-over-year decline in Share-based Compensation ran from 11.0% in Q1 2025 to 59.7% in Q1 2024.
- Per Business Quant data, NVAX's Share-based Compensation in the three quarters before Q2 2026 was $7.72 million (Q1 2026), $7.97 million (Q4 2025) and $8.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn | 8.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.09 Mn |
| Mar 31, 2026 | 7.72 Mn |
| Dec 31, 2025 | 7.97 Mn |
| Sep 30, 2025 | 8.55 Mn |
| Jun 30, 2025 | 9.21 Mn |
| Mar 31, 2025 | 10.29 Mn |
| Dec 31, 2024 | 10.45 Mn |
| Sep 30, 2024 | 12.05 Mn |
| Jun 30, 2024 | 14.10 Mn |
| Mar 31, 2024 | 11.56 Mn |
| Dec 31, 2023 | 15.66 Mn |
| Sep 30, 2023 | 20.76 Mn |
| Jun 30, 2023 | 20.29 Mn |
| Mar 31, 2023 | 28.65 Mn |
| Dec 31, 2022 | 27.78 Mn |
| Sep 30, 2022 | 31.54 Mn |
| Jun 30, 2022 | 38.05 Mn |
| Mar 31, 2022 | 32.93 Mn |
| Dec 31, 2021 | 32.17 Mn |
| Sep 30, 2021 | 45.27 Mn |
API Access
Novavax Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();